230 related articles for article (PubMed ID: 28228253)
1. SIRT6 Suppresses Cancer Stem-like Capacity in Tumors with PI3K Activation Independently of Its Deacetylase Activity.
Ioris RM; Galié M; Ramadori G; Anderson JG; Charollais A; Konstantinidou G; Brenachot X; Aras E; Goga A; Ceglia N; Sebastián C; Martinvalet D; Mostoslavsky R; Baldi P; Coppari R
Cell Rep; 2017 Feb; 18(8):1858-1868. PubMed ID: 28228253
[TBL] [Abstract][Full Text] [Related]
2. The histone deacetylase SIRT6 suppresses the expression of the RNA-binding protein PCBP2 in glioma.
Chen X; Hao B; Liu Y; Dai D; Han G; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
Biochem Biophys Res Commun; 2014 Mar; 446(1):364-9. PubMed ID: 24607900
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
4. Autophagy induction by SIRT6 through attenuation of insulin-like growth factor signaling is involved in the regulation of human bronchial epithelial cell senescence.
Takasaka N; Araya J; Hara H; Ito S; Kobayashi K; Kurita Y; Wakui H; Yoshii Y; Yumino Y; Fujii S; Minagawa S; Tsurushige C; Kojima J; Numata T; Shimizu K; Kawaishi M; Kaneko Y; Kamiya N; Hirano J; Odaka M; Morikawa T; Nishimura SL; Nakayama K; Kuwano K
J Immunol; 2014 Feb; 192(3):958-68. PubMed ID: 24367027
[TBL] [Abstract][Full Text] [Related]
5. High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects.
Yu J; Wu Y; Yang P
J Neurochem; 2016 May; 137(3):371-83. PubMed ID: 26896748
[TBL] [Abstract][Full Text] [Related]
6. K-Ras-PI3K regulates H3K56ac through PCAF to elevate the occurrence and growth of liver cancer.
Gao X; Cheng Z; Yuan H; Zhao H
J Cell Physiol; 2020 Apr; 235(4):3905-3915. PubMed ID: 31642074
[TBL] [Abstract][Full Text] [Related]
7. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth.
Sharma N; Nanta R; Sharma J; Gunewardena S; Singh KP; Shankar S; Srivastava RK
Oncotarget; 2015 Oct; 6(31):32039-60. PubMed ID: 26451606
[TBL] [Abstract][Full Text] [Related]
8. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism.
Sebastián C; Zwaans BM; Silberman DM; Gymrek M; Goren A; Zhong L; Ram O; Truelove J; Guimaraes AR; Toiber D; Cosentino C; Greenson JK; MacDonald AI; McGlynn L; Maxwell F; Edwards J; Giacosa S; Guccione E; Weissleder R; Bernstein BE; Regev A; Shiels PG; Lombard DB; Mostoslavsky R
Cell; 2012 Dec; 151(6):1185-99. PubMed ID: 23217706
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation.
Almozyan S; Colak D; Mansour F; Alaiya A; Al-Harazi O; Qattan A; Al-Mohanna F; Al-Alwan M; Ghebeh H
Int J Cancer; 2017 Oct; 141(7):1402-1412. PubMed ID: 28614911
[TBL] [Abstract][Full Text] [Related]
10. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
[TBL] [Abstract][Full Text] [Related]
11. E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells.
Wu M; Seto E; Zhang J
Oncotarget; 2015 May; 6(13):11252-63. PubMed ID: 25816777
[TBL] [Abstract][Full Text] [Related]
12. Identification of and Molecular Basis for SIRT6 Loss-of-Function Point Mutations in Cancer.
Kugel S; Feldman JL; Klein MA; Silberman DM; Sebastián C; Mermel C; Dobersch S; Clark AR; Getz G; Denu JM; Mostoslavsky R
Cell Rep; 2015 Oct; 13(3):479-488. PubMed ID: 26456828
[TBL] [Abstract][Full Text] [Related]
13. Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway.
He K; Xu T; Xu Y; Ring A; Kahn M; Goldkorn A
Int J Cancer; 2014 Jan; 134(1):43-54. PubMed ID: 23784558
[TBL] [Abstract][Full Text] [Related]
14. Sirt6 suppresses hepatocellular carcinoma cell growth via inhibiting the extracellular signal‑regulated kinase signaling pathway.
Zhang ZG; Qin CY
Mol Med Rep; 2014 Mar; 9(3):882-8. PubMed ID: 24366394
[TBL] [Abstract][Full Text] [Related]
15. EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop.
Yang CF; Yang GD; Huang TJ; Li R; Chu QQ; Xu L; Wang MS; Cai MD; Zhong L; Wei HJ; Huang HB; Huang JL; Qian CN; Huang BJ
Oncogene; 2016 Jun; 35(26):3419-31. PubMed ID: 26568302
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological activation of SIRT6 triggers lethal autophagy in human cancer cells.
Iachettini S; Trisciuoglio D; Rotili D; Lucidi A; Salvati E; Zizza P; Di Leo L; Del Bufalo D; Ciriolo MR; Leonetti C; Steegborn C; Mai A; Rizzo A; Biroccio A
Cell Death Dis; 2018 Sep; 9(10):996. PubMed ID: 30250025
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ
Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296
[TBL] [Abstract][Full Text] [Related]
18. SIRT6 Controls Hematopoietic Stem Cell Homeostasis through Epigenetic Regulation of Wnt Signaling.
Wang H; Diao D; Shi Z; Zhu X; Gao Y; Gao S; Liu X; Wu Y; Rudolph KL; Liu G; Li T; Ju Z
Cell Stem Cell; 2016 Apr; 18(4):495-507. PubMed ID: 27058938
[TBL] [Abstract][Full Text] [Related]
19. [Phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway is critical for survival and proliferation of pancreatic cancer stem-like side population cells].
Zhou J; Wang CY; Liu T; Wu HS; Zhou F; Xiong JX; Zhao G; Yang M; Yin T; Zhou MT
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):2994-8. PubMed ID: 19080079
[TBL] [Abstract][Full Text] [Related]
20. USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation.
Lin Z; Yang H; Tan C; Li J; Liu Z; Quan Q; Kong S; Ye J; Gao B; Fang D
Cell Rep; 2013 Dec; 5(6):1639-49. PubMed ID: 24332849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
